A Retrospective Database Analysis of Neonatal Morbidities to Evaluate a Composite Endpoint for Use in Preterm Labor Clinical Trials

Author:

Pimenta Jeanne1,Ebeling Myla2,Montague Timothy3,Beach Kathleen4,Abell Jill56,O'Shea Michael7,Powell Marcy8,Hulsey Thomas29

Affiliation:

1. Real World Evidence (Epidemiology), GSK, Uxbridge, Middlesex, United Kingdom

2. Division of Neonatology, Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina

3. Clinical Statistics, GSK, Philadelphia, Pennsylvania

4. Maternal Neonatal Health Unit, GSK, Research Triangle Park, North Carolina

5. Clinical Effectiveness and Safety Clinical Evaluation Science, GSK, Philadelphia, Pennsylvania

6. Janssen Scientific Affairs, Real World Evidence, Philadelphia, Pennsylvania

7. Department of Pediatrics (Neonatology Section), University of North Carolina, Chapel Hill, North Carolina

8. Safety Evaluation and Risk Mitigation, GSK, Research Triangle Park, North Carolina

9. Department of Epidemiology, West Virginia University, Morgantown, West Virginia

Abstract

Objective To propose and assess a composite endpoint (CE) of neonatal benefit based on neonatal mortality and morbidities by gestational age (GA) for use in preterm labor clinical trials. Study Design A descriptive, retrospective analysis of the Medical University of South Carolina Perinatal Information System database was conducted. Neonatal morbidities were assessed for inclusion in the CE based on clinical significance/risk of childhood neurodevelopmental impairment, frequency, and association with GA in a mother–neonate linked cohort, comprising women with uncomplicated singleton pregnancies delivered at ≥24 weeks' GA. Results Among 17,912 mother–neonate pairs, neonates were at a risk of numerous severe but infrequent morbidities. Clinically important, predominantly rare events were combined into a CE comprising neonatal mortality and morbidities, which decreased in frequency with increasing GA. The highest CE frequency occurred at <31 weeks. High frequency of respiratory distress syndrome, bronchopulmonary dysplasia, and sepsis drove the CE. Median length of hospital stay was longer at all GAs in those with the CE compared with those without. Conclusions Descriptive epidemiological assessment and clinical input were used to develop a CE to measure neonatal benefit, comprising clinically meaningful outcomes. These empirical data and CE allowed trials investigating tocolytics to be sized appropriately.

Publisher

Georg Thieme Verlag KG

Subject

Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3